Emulgel: A new platform for topical drug delivery

International Journal of Pharma and Bio Sciences

Volumn 3, Issue 1, 2012, Pages P485-P498

  Singla, Vikas ^a   Saini, Seema ^a   Joshi, Baibhav ^a   Rana, A C ^a  

^a Rayat Institute of Pharmacy   (India)

Author keywords

Emulgels; Hydrophobic drugs; Penetration enhancers; Topical delivery

Indexed keywords

ACECLOFENAC; ACECLOFENAC PLUS CAPSAICIN PLUS METHYLSALICYLATE; ADAPALENE PLUS CLINDAMYCIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; BENZOYL PEROXIDE; CARBOPOL 934; CHLORPHENESIN; CLINDAMYCIN PHOSPHATE ALLANTOIN; CLOBETASOL PROPIONATE; DICLOFENAC; DICLOFENAC DIETHYLAMINE; FLUCONAZOLE; HYDROCORTISONE PLUS MICONAZOLE NITRATE; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; ITRACONAZOLE; KETOCONAZOLE; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; METRONIDAZOLE; MICONAZOLE; NADIFLOXACIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; TEZAROTENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALDECOXIB;

ADHESION; ARTICLE; DERMIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; EMULGEL; EMULSION; EPIDERMIS; GEL; HUMAN; NONHUMAN; PATCH TEST; PHYSICAL CHEMISTRY; SHELF LIFE; SKIN ABSORPTION; SUBCUTANEOUS TISSUE; THIXOTROPY; TOPICAL TREATMENT;

EID: 84879609066     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. C. Surver and F.A. Davis, Bioavailability and Bioequivaance, In: K.A Walter (eds.), Dermatological and Transdermal Formulation, Marcal Dekker, New York, 2002, pp. 323- 327,403.
2. Sharma S. Topical drug delivery system. Available from: http://www.pharmainfo.net/Section/science-news/. [Cited in 2011 Aug 9].
3. Kuller R, Saini S, Seth N, Rana AC, Emulgel: A surrogate approach for topical used hydrophobic drugs. Int J Pharm Bio Sci, 1(3):117-128, (2011).
4. Jain A, Gautam SP, Gupta, Jain S, Development and characterization of Ketoconazole emulgel for topical drug delivery. Der Pharmacia Sinica, 1(3):221-231, (2010).
5. Stan-posthumd JJ, Vink J, Bruijn JA, Topical Tretinoin under occlusion on a typical navei. 548, (1998).
6. Mohamad MI, Optimization of chlorphenesin emulgel formulation. The AAPS journal, 6(3):1-5, (2004).
7. Kumar L, Verma R, In vitro evaluation of topical gel prepared using natural polymer. Int J drug deli, 2:58-63, (2010).
8. Mitkari BV, Korde SA, Mahadik KR, Kokare CR, Formulation and evaluation of topical liposomal gel for Fluconazole. Indian journal of pharmaceutical education and research, 44(4):324-329, (2010).
9. Wang M, Fang L, Percutaneous absorption of Diclofenac acid and its salts from emulgel. Asian journal of pharmaceutical sciences, 3(3): 131-138, (2008).
10. Singh S, Gajra B, Rawat M, Muthu MS, Enhanced Transdermal delivery of Ketoprofen from bioadhesive gels. Pak. Journal of pharmaceutical science, 22 (2):193-198, (2009).
11. Barhate SD, Development of Meloxicam sodium transdermal gel. Int J Pharm Res Dev, 2(5):1-4, (2011).
12. Jain A, Deveda P, Vyas N, Jain S, Development of antifungal emulsion based gel for topical fungal infection, Int J Pharm Res Dev, 2(12):18-23, (2011).
13. Khuller R. Kumar D, Seth N, Saini S, Formulation and evaluation of Mefenamic acid emulgel for topical delivery, Saudi Pharm Sci, (2011).
14. Deveda P, Jain A, Vyas N, Jain S, Khambete H, Gellified emulsion for sustain delivery of Itraconazole for topical fungal diseases, Int J pharm Sci, 2(1):104-112, (2010).
15. Patel J, Patel B, Kaushal P, Patel M, Formulation and evaluation of topical Aceclofenac gel using different gelling agent. Int J Drug Dev Res, 3(1):156-163, (2011).
16. Rasool BKA, Gharbieh EFA, Sohar AF, Khan SA, Development and evaluation of ibufrofen Transdermal gel formulation, Tropical J Pharm Res, 9(4):355-363, (2010).
17. Setty CM, Babubahi SR, Pathan IB, Development of Veldecoxib topical gels: Effect of formulation variables on the release of valdecoxib, Int J Pharm Pharma Sci, 2(1):70-73, (2010).
18. Nayank SH, Nkhat PD, Yeole PG, The Indian Pharmacist,3(27):7-14,(2004).
19. Devada P, Jain A, Vyas N, Jain S. Development of antifungal emulsion based gel for topical fungal infection. Int J Pharm Res Dev ,3(2):18-25, (2011).
20. Mishra AN, Ed. Controlled and novel drug delivery, 4th Edn, CBS Publishers and distributers: 107-109, (1997).
21. Nandu S, et al. Ind J Pharm Sci, 60(4): 185-188, (1998).
22. Kumari P, Shankar C, Mishra B. The Indian Pharmacist, 24:7-16, (2004).
23. Kanikkannan N, Kandimalla K, Lamba SS, Singh M, Structure activity relationship of chemical penetration enhancers in transdermal drug delivery. Current med chem,6:593-608, (1999).
24. Singh PB. Choudhary PK, Penetration enhancers for transfer drug delivery of systemic agents, J Pharm Res, 6:44-50, (2007).
25. Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev, 48:159-172, (2001).
26. Ayub, CA, Gomes ADM, Lima MVC, Vianna-Soares CD, Ferreira LMA. Topical Delivery of Fluconazole: In Vitro Skin Penetration and Permeation Using Emulsions as Dosage Forms Drug. Dev. Ind. Pharm, 33:273-280, (2007).
27. Gaur PK, Mishra S, Purohit S, Dave K. Transdermal Drug Delivery System: A Review. AJPCR, 2: 14-20, (2009).
28. Subranayam N, Ghosal SK, Moulik SP. Enhanced In Vitro Percutaneous Absorption and In Vivo Anti-Inflammatory Effect of a Selective Cyclooxygenase Inhibitor Using Microemulsion. Drug Dev. and Industrial Pharm.,5:43-48, (2008).
29. Pathan, I.B.; Setty, C.M. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res, 8:173-179, (2009).
30. Rashmi MS. Topical Gel: A Review, 2008. Available from: http://www.pharmainfo.net/review/topical-gel-review.
31. Bonacucina G, Cespi M, Palmieri GF, Characterization and Stability of Emulsion Gels Based on Acrylamide/Sodium Acryloyldimethyl Taurate Copolymer. AAPS PharmSciTech, 10 (2): 34-45, (2009).
32. Curr AEB. Transdermal Drug Delivery: Penetration Enhancement Techniques Heather. Drug Deliv, 5(2):23-33, (2005).
33. Rutrer N, Drug absorption through the skin: a mixed blessing. Arch Dis Child, 62:220-221, (1987).
34. Zhang XL, Zhao R, Qian W. Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. Chin Pharm J, 30:417-418, (1995).
35. Swarbrick, J. Encyclopedia of pharmaceutical technology, 3rd ed.,1551.
36. WB Saunders Co. Philadelphia, 1970, 55-60.
37. Kasliwal N, Derle D, Negi J, Gohil J. Effect of permeation enhancers on the release and permeation kinetics of meloxicam gel formulations through rat skin. Asian J Pharma Sci, 3 (5): 193-199, (2008).
38. Sanjay, Jain BD, Padsalg A, Patel K, Mokale V, Formulation, development and evaluation of Fluconazole gel in various polymer bases, Asi J Pharm, 1:63-68, (2007).
39. Singh S, Gajra B, Rawat M, Muthu MS. Enhanced Transdermal Delivery Of Ketoprofen From Bioadhesive Gels. Available at http://www.google.com.
40. Rathore RPS, Nema RK, Formulation and evaluation of topical gels of Ketoprofen, Asian J Pharm Clinical. Res 1:12-16, (2008).
41. Gupta GD, Gound RS. Release rate of nimesulide from different gellants. Indian J Pharm Sci, 61(1): 229-23, (1999).
42. Patel RP, Patel G, Baria A. Formulation and evaluation of transdermal patch of aceclofenac, Int J Drug Del, 1(3): 41-51, (2009).
43. Chaudhari P, Ajab A, Malpure P, Kolsure P, Sanap D, Development and in-vitro evaluation of thermo reversible nasal gel formulations of Rizatriptan benzoate, Indian J Pharm Edu Res,43: 55-62, (2009).
44. Jones DB, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm,151:223-33, (1997).